Single Amino Acid Mutation Governs Andes Virus Pathogenicity in Human Cells
Researchers have identified a single genetic substitution that alters how the Andes virus processes its proteins and releases particles inside human cells. The finding helps explain the biological mechanics of the only hantavirus known to spread directly between people.
By Logan Price
Share this story
Andes virus stands alone among its peers. While most hantaviruses require humans to inhale aerosolized rodent excreta to cause infection, Andes virus possesses the rare ability to spread directly from person to person.[5]
Hantaviruses are typically divided into Old World and New World lineages. Old World variants, found primarily in Europe and Asia, generally cause hemorrhagic fever with renal syndrome, while New World variants in the Americas trigger severe respiratory distress.[5]
The Andes virus is the most prominent New World strain in South America, endemic to the Patagonia region spanning southern Argentina and Chile. Its natural reservoir is the long-tailed pygmy rice rat, which sheds the virus into the environment.[5]
That unique transmission capability has made it a priority for virologists studying how animal pathogens adapt to human hosts. Now, researchers have pinpointed a microscopic genetic shift that alters how the virus operates inside human cells.[1][2]
A team at the Icahn School of Medicine at Mount Sinai identified a single amino acid difference between rodent-derived and human-derived isolates of the Andes virus. The substitution changes how a key viral glycoprotein moves through cellular compartments.[2][4]
Published November 6, 2026, in the journal Science Advances, the findings offer a mechanical explanation for biological differences between closely related viral strains. The discovery dictates how quickly new virus-like particles are released from infected cells.[1][3]
"Understanding how such a small molecular difference can affect viral protein processing and the release of new viral particles could help identify new targets for antiviral therapies," said Santiago Vidal-Freire, the study's first author.[4]
The Epuyén Outbreak
To understand the virus's human adaptation, the Mount Sinai team, led by Gustavo Palacios, compared two specific viral isolates. The first was a standard Andes virus isolate taken directly from a rodent host.[2][4]
The second was a human-derived isolate collected during a severe outbreak in Epuyén, Argentina, that spanned from late 2018 into early 2019. The Epuyén cluster remains one of the most significant hantavirus events on record.[2]
According to the Pan American Health Organization, the outbreak resulted in 34 confirmed cases and 11 deaths in the Chubut province. The 2018-2019 event was characterized by documented person-to-person transmission, including superspreader events that passed through four generations of contacts.[5]
The scale of the Epuyén outbreak forced local authorities to implement strict quarantine measures, isolating approximately 100 residents by judicial order to break the chain of transmission. The aggressive public health response highlighted the virus's unique threat profile.[5]
Andes virus causes hantavirus pulmonary syndrome, a severe respiratory illness with a high fatality rate. In the Epuyén outbreak, the mortality rate approached 32 percent, underscoring the pathogen's lethality once it adapts to human hosts.[2]
Virologists have long sought to understand what makes the Andes virus capable of such sustained human-to-human spread when closely related strains, like the Sin Nombre virus in North America, strictly rely on rodent-to-human transmission.[1]
Previous research had already established that the rodent and human isolates behaved differently in laboratory settings, despite being genetically similar. The rodent-derived isolate consistently grew faster than its human-derived counterpart, prompting researchers to search for the mechanical cause.[2][4]
Cellular Bottlenecks
Genomic analysis revealed 25 amino acid differences between the two isolates. The researchers narrowed their focus to a single substitution located near the glycoprotein cleavage domain, a region critical for processing and assembling new viral particles.[1][4]
The team wanted to know if this single mutation could explain the differing growth rates. Initial tests showed no major changes in viral RNA production between the two isolates, meaning the genetic material was replicating normally.[2][4]
Because RNA synthesis was equivalent, the researchers deduced that the bottleneck was occurring during the later stages of the viral lifecycle. To test their hypothesis, the team engineered a specialized molecular expression system to isolate the protein's behavior.[1][4]
They altered one amino acid in the human-derived isolate's glycoprotein, changing it from a threonine to an isoleucine to match the rodent-derived version. The modification produced an immediate mechanical change inside the human cells.[1][4]
The altered glycoprotein spent significantly less time trapped in the Golgi apparatus, the cellular compartment responsible for processing and packaging proteins. Because Andes virus particle assembly takes place at the Golgi apparatus, this retention time is crucial.[2][4]
The Golgi apparatus functions as the cell's central shipping and receiving center, modifying proteins and lipids before packaging them into vesicles for delivery. Viruses frequently hijack this machinery to assemble their own structural components.[1][4]
By lingering in the Golgi apparatus, the human-adapted Andes virus glycoprotein alters the timeline of viral assembly. The researchers observed that the single amino acid substitution directly governed this retention phase, acting as a molecular timer.[2][4]
The engineered protein's faster transit allowed virus-like particles to be released from the cell more quickly. The findings suggest that the mutation present in the human isolate might represent a complex evolutionary trade-off during human adaptation.[1][3]
Evolutionary Trade-offs
While the human variant releases particles more slowly in vitro, the mutation may confer other advantages for human infection. The delayed release of virions could theoretically help the virus evade early immune detection, though this hypothesis requires further testing.[1][4]
"We still know relatively little about the viral features that may influence how Andes virus behaves in humans," Palacios noted. He emphasized the complexity of viral adaptation and the need to map these cellular interactions across different species.[4]
Identifying the Golgi apparatus as a critical bottleneck for Andes virus assembly provides a concrete cellular mechanism for researchers to target. Disrupting this specific protein processing pathway could form the basis of future targeted treatments.[3][4]
Identifying the Golgi apparatus as a critical bottleneck for Andes virus assembly provides a concrete cellular mechanism for researchers to target.
Traditional antiviral development often focuses on blocking viral entry into the cell or inhibiting RNA replication. By contrast, targeting the assembly and egress phases at the Golgi apparatus represents a novel therapeutic angle for hantaviruses.[3][4]
If a drug could artificially prolong the glycoprotein's retention in the Golgi apparatus, it might slow the release of new virions enough to give the patient's immune system time to mount an effective defense.[1][4]
Currently, there are no specific antiviral drugs or vaccines approved to treat or prevent hantavirus pulmonary syndrome. Medical care is limited to supportive therapies, making the discovery of new molecular targets highly valuable for public health.[2]
Experimental Limitations
The authors were careful to outline the boundaries of their current findings. The cellular experiments relied on molecular expression systems and non-infectious virus-like particles rather than deploying the complete, live Andes virus in the laboratory.[3][4]
Because the study did not use genetically modified infectious virus, the results do not definitively prove that this single amino acid change is the sole driver of person-to-person transmission. Viral adaptation to a new host is rarely dictated by a single mutation.[2][4]
Key points
- Mount Sinai researchers found that a single amino acid difference alters how Andes virus glycoproteins move through human cells.
- The study compared a rodent-derived viral isolate with a human-derived isolate from a deadly 2018–2019 outbreak in Argentina.
- Engineering the human viral protein to match the rodent version accelerated the release of virus-like particles from the Golgi apparatus.
- The discovery provides a new mechanical target for developing antiviral therapies against hantavirus pulmonary syndrome.
What we don’t know
- Whether this single amino acid substitution is the primary driver of the virus's unique ability to spread from person to person.
- How the other 24 amino acid differences identified between the rodent and human isolates contribute to viral adaptation.
- How this specific glycoprotein mutation interacts with the human immune system during a live, complete viral infection.
- Molecular Virologists
- Focus on identifying the specific genetic and mechanical changes that allow zoonotic viruses to adapt to human cellular machinery.
- Public Health Epidemiologists
- Emphasize the clinical outcomes of viral adaptation, tracking how molecular changes translate into outbreak severity and transmission chains.
Perspectives this story doesn't cover
- Clinical physicians treating hantavirus patients
- Residents of the Patagonia region affected by endemic Andes virus
Sources
[1]Science AdvancesMolecular VirologistsA single–amino acid difference between rodent and human Andes virus affects viral glycoprotein trafficking
Read on Science Advances →
[2]Mount Sinai Health SystemMolecular VirologistsMount Sinai Study Identifies Single Amino Acid Change That Alters Andes Virus Protein Behavior in Human Cells
Read on Mount Sinai Health System →
[3]News-MedicalMolecular VirologistsSingle amino acid change alters Andes virus protein behavior
Read on News-Medical →
[4]BiocompareMolecular VirologistsSingle Amino Acid Change Alters Andes Virus Glycoprotein Behavior in Human Cells
Read on Biocompare →
[5]Pan American Health OrganizationPublic Health EpidemiologistsEpidemiological Update: Hantavirus Pulmonary Syndrome
Read on Pan American Health Organization →
More in Science
See all →Evolutionary Genetics
Inherited Neanderthal Gene Variant Linked to Lower Schizophrenia Risk in Modern Humans
5 sources
Gene Therapy Oversight
Shanghai Dismisses Scientists Following Child's Death in Unapproved Brain Gene-Editing Trial
7 sources
Genetic Networks
X-Linked ZFX Gene Regulates Genetic Networks Shielding Females From Autism
5 sources
Archaeogenetics
Ancient DNA Analysis Traces the Prehistoric Spread of Germanic and Celtic Languages
4 sources
Comments
Every angle. Every day.
Get Science stories with full source coverage and perspective breakdowns, free every day.




